HBM HOLDINGS-B2142.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, HBM HOLDINGS-B (2142.HK) trades at a P/E of 14.30x, P/B of 2.87x, P/S of 6.72x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 43rd percentile over the trailing 10Y window (vs. 43rd percentile over 3Y); P/B sits at the 63rd percentile over the trailing 10Y window (vs. 44th percentile over 3Y); P/S sits at the 36th percentile over the trailing 10Y window (vs. 42nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 46th percentile within its industry and the 62nd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.60%, ranking at the 93rd percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 20.2 points — relying on either metric alone could be misleading. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. HBM HOLDINGS-B operates in the Biomedical II sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 2142 · SEHK: 2142 · 2142
Want the full picture on whether HBM HOLDINGS-B (2142.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 14.30 | ||||||
| P/B (MRQ) | 2.87 | ||||||
| P/S (TTM) | 6.72 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 1.60% |